The latest review of the iBCS as presented at the 4th PQRI/FDA Conference

Jayne Hastedt presented “Biopharmaceutical Classification of Inhaled Medicines: Development of an iBCS;” at the 4th PQRI/FDA Conference on Advancing Product Quality: Patient-Centric Product Design, Drug Development, and Manufacturing. Rockville, MD (2019).